Akshay Vaishnaw

Insider Reports History

Entity
Individual
Location
300 Third Street, Cambridge, Massachusetts
Signature
/s/ Junlin Ho, Attorney-in-Fact for Akshay Vaishnaw
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Akshay Vaishnaw:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. President Common Stock 22,774 $4.22 M $185.32 Aug 4, 2023 Direct
Scholar Rock Holding Corp Director Common Stock 22,955 $206 K $8.99 Jun 27, 2024 Direct
ALNYLAM PHARMACEUTICALS, INC. President Common Stock 515 $95.4 K $185.32 Aug 3, 2023 by Managed Account
Editas Medicine, Inc. Director Stock Option (right to buy) 25,000 May 30, 2024 Direct
Scholar Rock Holding Corp Director Stock Option (Right to Buy) 18,000 Jun 27, 2024 Direct

Insider Reports Filed by Akshay Vaishnaw

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRRK Scholar Rock Holding Corp Jun 27, 2024 2 0 4 Jul 1, 2024 Director
EDIT Editas Medicine, Inc. May 30, 2024 1 0 4 Jun 3, 2024 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 3, 2023 8 -753,986 4 Aug 7, 2023 President
SRRK Scholar Rock Holding Corp Jun 21, 2023 1 0 4 Jun 22, 2023 Director
EDIT Editas Medicine, Inc. Jun 1, 2023 1 0 4 Jun 5, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Apr 26, 2023 6 -465,464 4 Apr 28, 2023 President
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 27, 2023 2 0 4 Mar 1, 2023 President
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 10, 2023 7 -6,268,805 4 Feb 14, 2023 President
ALNY ALNYLAM PHARMACEUTICALS, INC. Dec 5, 2022 7 449 4 Dec 7, 2022 President
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 3, 2022 7 -1,160,335 4 Aug 5, 2022 President
SRRK Scholar Rock Holding Corp Jun 16, 2022 1 0 4 Jun 21, 2022 Director
EDIT Editas Medicine, Inc. Jun 9, 2022 1 0 4 Jun 13, 2022 Director
SRRK Scholar Rock Holding Corp May 26, 2022 1 0 4 May 27, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 23, 2022 1 0 4 Feb 25, 2022 President
ALNY ALNYLAM PHARMACEUTICALS, INC. Dec 31, 2021 1 0 4 Jan 4, 2022 President
ALNY ALNYLAM PHARMACEUTICALS, INC. Dec 21, 2021 21 -1,029,388 4 Dec 23, 2021 President, R&D
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 9, 2021 3 -1,484,258 4 Aug 11, 2021 President, R&D
ALNY ALNYLAM PHARMACEUTICALS, INC. Jun 18, 2021 5 -1,850,405 4 Jun 22, 2021 President, R&D
EDIT Editas Medicine, Inc. Jun 3, 2021 1 0 4 Jun 7, 2021 Director
SRRK Scholar Rock Holding Corp May 27, 2021 1 0 4 Jun 1, 2021 Director